Carbon quantum dots (CQDs) have emerged as potential alternatives to classical metal-based semiconductor quantum dots (QDs) due to the abundance of their precursors, their ease of synthesis, high biocompatibility, low cost, and particularly their strong photoresponsiveness, tunability, and stability. Light is a versatile, tunable stimulus that can provide spatiotemporal control. Its interaction with CQDs elicits interesting responses such as wavelength-dependent optical emissions, charge/electron transfer, and heat generation, processes that are suitable for a range of photomediated bioapplications. The carbogenic core and surface characteristics of CQDs can be tuned through versatile engineering strategies to endow specific optical and physicochemical properties, while conjugation with specific moieties can enable the design of targeted probes. Fundamental approaches to tune the responses of CQDs to photo-interactions and the design of bionanoprobes are presented, which enable biomedical applications involving diagnostics and therapeutics. These strategies represent comprehensive platforms for engineering multifunctional probes for nanomedicine, and the design of QD probes with a range of metal-free and emerging 2D materials.
Introduction
The integration of light with nanotechnology and biology has given rise to exciting new developments in nanobiophotonics [1] . This is an emerging research area that offers unprecedented opportunities for the precise, noninvasive analysis of structures and functions, from the organ-to molecular-scale, with a ultrahigh resolution. Nanoscale fluorescent materials are particularly important in nanobiophotonics as they produce intense and stable responses to incident light, providing unique tools such as optical emission, charge/electron transfer, and in situ heat generation for diverse photomediated bioapplications [2, 3] .
To date, researchers have developed several types of luminescent nanomaterials, including semiconductor quantum dots (QDs), dye-doped nanoparticles, up-converting lanthanide-doped nanoparticles, polymer dots, QDs derived from 2D materials, and carbon nanodots [4] . Compared with existing small-molecule dyes and fluorescent proteins, these luminescent nanoprobes exhibit improved photophysical properties, Nano Res. 2018, 11(1): 1-41 large surface-to-volume ratios, and facile tunability of the surface, color, and other characteristics. Among them, carbon quantum dots (CQDs) have emerged as candidates with high potentials, since other nanomaterials either suffer from toxicity, photobleaching, low stability, or a lack of tunability.
Typically, CQDs have diameters below 10 nm and possess properties that place them between isolated atoms and larger nanoparticles. A CQD smaller than its exciton Bohr radius can luminesce when the quantum confinement effects dominate. Within a CQD, the heterogeneous size distribution of sp 2 π-conjugated islands in an sp 3 non-conjugated matrix creates discrete energy levels, leading to the observation of dramatically different optical, electrical, and chemical properties compared to other nanoparticles. The distinctive features of CQDs include their broad absorption, tunable photoluminescence (PL), exceptional photostability, large Stokes shift, high emission rates, two-photon excitation in the near-infrared (NIR) region, photoexcited electron transfer characteristics, and photo-induced in situ heat generation [5] [6] [7] [8] . These unique properties have potential in a range of photomediated applications in bioimaging, sensing, delivery, and therapy.
Tailoring CQDs with organic molecules generates advanced biocompatible probes for use in the multiplexed quantitative analysis of cellular phenotypes, real-time monitoring of intracellular processes, in vivo molecular imaging, photo-triggered delivery systems, and destruction of cancer cell ensembles. CQDs provide a platform for engineering multifunctional nanodevices able to exploit multiple imaging modalities or combine imaging and therapeutic functionalities within a single nanoparticle. Utilization of their unique photophysical and chemical properties can address challenging issues in biomedical research, such as enabling efficient bioprobes, traceable drug delivery vehicles, and multifunctional therapeutics. Active exploration of CQD-based biomedical applications has resulted in an exponential growth in peer-reviewed publications since 2004 [9] .
This review outlines the key achievements of CQDs in nanobiophotonics, as highlighted in Fig. 1 , regarding recent diagnostic and therapeutic developments. The evaluation of CQDs for translational medicine is beyond the scope of the current review and are given elsewhere [10] . Our review covers the photoresponsive properties and design principles of CQDs for biomedical probes, relating to carbogenic core design, surface engineering, and strategies for the conjugation of functional molecules. In particular, we present the use of CQDs in diagnosing pathological cells, as molecular markers via photomediated sensing, in targeted imaging, along with image-mediated therapeutic delivery, photodynamic therapy (PDT), and photothermal therapy (PTT) within in vitro and in vivo settings. Finally, we outline the recent developments of CQD-based multifunctional platforms in multimodal imaging and multifunctional theranostics.
Principal responses generated by light-CQD interactions
The key mechanism of CQD activity used in photomediated bioapplications involves the absorption of electromagnetic radiation and its conversion into various forms of energy. The photoresponse of a CQD is dependent on its photon absorption cross section and quantum yield (QY), i.e., the number of events per absorbed photon for each particle, where an ''event'' can be photon release, electron transfer, or heat generation. The product of the absorption cross section and QY determines the efficiency of this energy conversion process. An understanding of the CQD photoresponse mechanisms helps guide the tuning of Nano Res. 2018, 11(1): 1-41 their properties, which will enable a wider range of applications with an enhanced versatility.
Photo-induced emissions
The most atypical characteristic of a CQD is its multifaceted PL, which is related to the large heterogeneity of its structure; hence, its PL is intriguingly determined by numerous parameters. Typically, CQDs are comprised of carbon core and surface domains, both of which are responsible (Fig. 2) for generating the diverse fluorescence (FL) properties [11] .
Carbogenic core-based emissions (1) Effect of chemical bonding and composition
The PL of carbon-based QDs is primarily caused by the bandgap generated by the quantum confinement of the conjugated π-electrons in the sp 2 carbon networks [12, 13] . This pristine intrinsic state emission is related to the radiative recombination of electron-hole pairs of the delocalized π-electrons upon the interaction between light and the clusters of sp 2 carbon [14, 15] . In reality, the isolated nanosized sp 2 islands are immersed in an sp 3 carbon-oxygen matrix, which resembles large aromatic molecules dispersed in non-conjugated carbon-oxygen polymers [16] . Hence, the ratio of sp 2 and sp 3 bonding in the carbon core dictates the overall bandgap and thereby the PL properties. It has been revealed that the green luminescence of oxygenated CQDs originated from sp 3 states, whereas the blue luminescence of less oxygenated CQDs was dominated by intrinsic states in the highly crystalline sp 2 structure [17] . Besides bonding, the chemical composition also significantly influences PL behavior. The three fundamental elements of CQDs are C, H, and O, and the ratios of these elements vary in different CQDs. The introduction of heteroatoms enables tuning of the conduction/valence band positions and confers additional functionality. For example, the QY of CQDs could be significantly improved by incorporating N [18] , while CQDs with wide bandgaps could be synthesized by incorporating S [19] . Furthermore, P-doped CQDs showed green FL with an enhanced imaging signal and a low background disturbance [20] . B was also found to act as an active site for charge transfer in CQDs [21] . L-cysteine-derived N and S co-doped CQDs produced deep-blue emissions, attributed to the S dopants strongly suppressing the excitation-dependent PL from the O surface states, while the N surface states facilitated the high yield of radiative recombination [22] . CQDs containing O and N radicals have been found to emit strong PL [23] , while the coexistence of O and Cl radicals resulted in Figure 2 Schematic representation of photoluminescence arising from the aromatic core and surface functional groups of carbon-based quantum dots (reproduced with permission from Ref. [11] , © the Royal Society of Chemistry 2016).
Nano Res. 2018, 11(1): high photoelectron transfer activity. This could be due to the different directions and degrees of energy band bending induced by O, Cl, and N radicals. Surface groups that contain O and N induce upward band bending, while Cl-containing surface groups induce downward band bending.
(2) Impact of intrinsic defect states
The defect sites in CQDs cause interesting emission properties, such as right-or left-shifted peaks, multicolored emissions, and QY tuning. Defects thereby make them suitable for multiplexing analyte sensing, and hierarchical bioimaging of full organs to single molecules. The defects throughout the carbogenic core, rather than its bulk surface, are identified as intrinsic defect states. Their degree can be primarily related to the ratio and distribution of conjugated π-and non-π-domains in the CQD. The strong light absorption by the conjugated π-domains is due to the high density of π-electrons swarming in the sp 2 hybridized islands. However, the introduction of defects-such as π-connections or sp 3 sites-between the sp 2 islands weakens the emission by trapping the excitons in non-radiative relaxation processes. Generally, more sp 3 trap sites result in more intrinsic defects, resulting in a right-shifted emission. The sp 3 states do not arise from single chemical groups but the hybridization of carbon backbones and different functional groups [13] . Therefore, various sp 3 energy levels are generated that result in a series of emissive traps upon excitation by different wavelengths of light. Thus, when radiation of a specific excitation wavelength strikes the CQD, a corresponding emissive trap is activated to emit a specific color. Increasing the number of sp 3 sites in the carbon backbone [24] significantly induced the non-radiative processes and reduced the integrity of the π-conjugated systems, thereby stimulating full-color emission from blue to red. To precisely understand the effects of defect sites requires further investigation.
PL decay measurements revealed that the mean radiative lifetime is in the range of 9.6-10.2 ns for the emission wavelengths of 471-577 nm. This makes it difficult to distinguish emission levels from surface states and those associated with n-π* transitions. Femtosecond time-resolved spectroscopy and Fourier transform infrared (IR) spectroscopy were combined to explore the common PL origin in CQDs to identify the functional surface groups responsible for FL [5] . The molecular state defect site is caused by the inter-penetrating association of organic fluorophore molecules with the CQD carbogenic framework. Molecular state PL was found to dominate in CQDs that were synthesized using small organic molecules. Small fluorophore molecules were formed at low reaction temperatures. As the carbonization temperature increased, the carbon core was generated by dehydration of the starting molecules or consumption of the formed fluorophores. For these CQDs, the PL related to the molecular states was strong with a high QY, while the carbon core states produced weak PL, albeit with a high photostability [13] .
(3) Effect of size Theoretical calculations showed that the bandgap increased to approximately 2 eV in CQDs consisting of 20 aromatic rings compared to 7 eV for benzene [25] . Thus, the PL emission of CQDs can be tuned via the size of the conjugated π-domains. Typically, an increase in particle size and aromatic ring conjugation decreases the π-π* transition bandgap, which causes the luminescence to be red-shifted to a lower energy. Size-dependent emission opens new avenues for multicolor bioimaging and multianalyte sensing. The synthesis and fractionation of CQDs according to size [26] showed that blue, green, yellow, and orange emissions were obtained with increasing size under identical excitations. The luminescence was attributed to quantum-sized graphite structures rather than the carbon-oxygen surface, since there were no significant changes in the PL spectra even after removal of the surface oxygen species. In contrast, an opposite trend was reported recently [27] where successively smaller CQDs (3.4, 2.9, and 2.2 nm) exhibited blue, yellow, and red FL under 365 nm UV excitations; here, the CQD sizes were regulated by varying the amount and structure of the precursors. These dissimilar results were defended on the basis that the sp 2 -domain sizes, not the particle sizes, dominated the quantum confinement effects. Thus, it was suggested that increasing the particle size might have increased the conjugated Nano Res. 2018, 11(1): 1-41 sp 2 -domains and decreased the surface defects, leading to more efficient emissions.
Bulk-and surface state-based emissions
(1) Influence of molecular anchoring The molecular deposition of both soft and hard materials on CQD surfaces significantly modifies the carbogenic PL behavior. Thus, doping the core carbon nanoparticle surface with an inorganic salt (ZnO, ZnS, or TiO 2 ) before chemical functionalization produced CQDs with a much brighter FL [28] . In another study, FL of Au/CQDs nanosytem, synthesized by wet chemistry, exhibited quenching due to ultrafast electron transfer arising from the specific complexation of molecules with CQDs [29] . Since CQDs are generally more fluorescent in the green and shorter wavelength regions, they are less desirable for use as bioimaging agents [30] . Hence, CQD-based hybrids have been synthesized for enhanced red and NIR FL emissions [31] . The host-guest concept was introduced to enhance the range of CQDs, by considering the carbon core as a solid-state spool to which dyes with a known red/NIR FL could be attached to generate the desired optical properties [32] . The selected dye-CQDs exhibited bright FL emissions in the green and red/NIR spectral regions. Similarly, photosensitizer (fluorescein)-conjugated CQDs also showed redshifted and enhanced emissions over their bare counterparts [33] .
(2) Effect of surface coatings Bare CQD surfaces are highly sensitive to intrinsic defect sites and the external environment. This sensitivity gives rise to uncontrolled photoemission and chemical instability, which poses challenges in designing CQD probes with high precision. Therefore, surface coatings such as thin polymeric layers are usually applied to facilitate the effective radiative recombination of surface-confined electrons and holes. PEGylation (poly(ethylene glycol) addition) has been widely used to enhance PL [34] . For example, PEG 1500N helped passivate CQDs and reach QYs as high as 60% [35] , outperforming the PL of commercial CdSe/ZnS semiconductor QDs in aqueous media. The crosslinking of several PEGylated CQDs also resulted in a sevenfold synergistic PL enhancement compared to single bare CQDs. Strong tunable FL emissions can also be achieved by surface layering using other polymers such as poly(propionyl ethyleneimine-co-ethyleneimine) (PPEI-EI) [36] . These exhibited a broad range of emissions extending from the visible to NIR regions. Branched polyethylenimine (b-PEI) has also acted as both a surface passivating and functionalizing agent, whereby the polyamines passivated the CQD surface which in turn was passivated by the free amine groups [37] . Apart from such soft coatings, coverage with hard materials also significantly influences PL. Confinement of CQDs in a silica matrix prevented external and self-quenching and so restricted nonradiative decay, leading to a dramatic improvement in FL intensity of up to 3,000 times that of a single CQD [38] .
External factor-dependent emissions
The excitation-dependent and tunable FL of CQDs provides the added advantageous ability to select the emission wavelengths depending on the excitation wavelengths; this is useful for efficient optical labeling and FL imaging. Such tunability can be achieved through the varied FL characteristics of particles with variable composition and size, and the distribution of different emissive sites on the surface of the CQD [39] . Most CQDs exhibit excitation wavelength-dependent emissions in the blue to green spectral ranges. However, excitation-independent behavior was also reported for CQDs having uniform sizes and emissive sites [40] .
Apart from conventional single-photon-excited down-conversion emissions, certain CQDs have shown up-conversion FL with multi-photon excitation [41] . This is an optical phenomenon whereby the emission wavelength is shorter than that of the applied excitation. This is particularly attractive because at longer wavelengths, especially in the NIR region, in vivo bioimaging is preferable owing to the improved deeptissue penetration and reduced background auto-FL. Up-conversion FL was realized with CQDs that emitted visible light on excitation by an IR femtosecond pulsed laser; the estimated multi-photon absorption cross section at 800 nm was 39,000 ± 5,000 GM (GoeppertMayer units, where 1 GM = 10 −50 cm 4 ·s/photon) [36] . This is comparable with other multi-photon luminescent Nano Res. 2018, 11(1): 1-41 materials: 780-10,300 GM for CdSe QDs at 800 nm [42] and 47,000 GM for CdSe/ZnS core/shell QDs at 605 nm [43] . A technical question arose relating to some of the apparent up-conversion FL emissions, which were identified as artifacts originating from conventional down-conversion emissions excited by leaking components from the second diffraction in the spectrofluorometer monochromator [44] . The leaking component can be removed by inserting a longpass filter into the excitation pathway. Thus, the interpretation of phenomena observed by the multiphoton irradiation of CQDs requires further attention.
Different dispersion factors such as pH, solvent, and concentration also significantly influence the final FL properties of CQDs. pH-dependent PL intensities have been reported. When the pH was changed from 5 to about 10, the FL intensity decreased [45] . On the other hand, the PL of CQDs was gradually enhanced on increasing the pH from 8 to 13 [46] . A pH-independent emission peak has also been observed and its origin was attributed to the bandgap instead of surface defect state emissions [47] . The changes in PL via pH can be attributed to the Fermi level change, which is caused by the protonation and deprotonation processes of CQD functional groups through electrostatic attraction/repulsion [48] . The PL of CQDs was found to be sensitive to the solvent type, as evidenced by PL peak shifts in tetrahydrofuran (THF), acetone, dimethylformamide (DMF), and water [49] . Solvent-dependent PL was induced by a lone electron pair that changed the electronic states of the CQDs and affected the final FL [50] . Time-resolved experiments on the nanosecond scale showed that broadening of the PL spectrum was related to slower relaxation of the solvent molecules around the CQDs [51] . The CQD concentration can also affect the PL properties including wavelength and intensity. An increase in CQD concentration resulted in a red-shift of the emission maximum [52] . A linear dependence of PL intensity was also observed at low concentrations (absorbance < 0.3), though it remained unchanged on increasing the concentration (> 0.6 mg/mL) [53] . NMPderived N-doped CQDs exhibited an excellent concentration-dependent full-color modulation which has potential applications in multimodal sensing and displays [54] .
Photostimulated electron transfer
The photo-induced exchange of electronic energy and electrons between connected molecular components is commonly used to obtain light-triggered functionalities in multicomponent systems [55] . Examples of this include in FL quenching, FL resonance energy transfer (FRET)-based sensing/delivery, and photodynamic therapy. The energy levels of the components must be correctly positioned relative to each other for these processes to be thermodynamically allowed. For example, if a CQD is in contact with a molecular electron acceptor with a LUMO energy lower than that of the conduction band edge, a photo-induced electron transfer (PET) from the CQD to the electron acceptor can occur ( Fig. 3 ) with consequent quenching of the luminescence. Conversely, if the CQD is linked to an electron donor with a HOMO energy greater than that of the valence band edge, electron transfer from the molecular donor to the photoexcited CQD, or hole transfer from the CQD valence band to the molecular HOMO, can occur ( Fig. 3(b) ). Another common quenching pathway involves the transfer of electronic energy between the CQD and a nearby molecular component. In the case of CQD-molecule conjugates, energy transfer usually takes place by the dipole-dipole (Förster) mechanism, which is frequently referred to as FRET. In most instances, CQD-molecule hybrids are designed such that the electronic energy is transferred from the photoexcited CQD to the molecular chromophore. On the other hand, bare CQDs or CQD-photosensitizer conjugates produce singlet oxygen and reactive oxygen species (ROS) on light irradiation by the transfer of excitation energy or electrons to oxygen. This is useful for applications in photodynamic therapy. The efficiency of ROS production can be improved by the conjugation of standard photosensitizers to high-quality CQDs. To utilize CQDs for light-to-energy and related conversions, investigations of their photoresponse, photo-induced charge separation, and electron transfer processes have shown that the PL from CQDs could be efficiently quenched in the presence of either electron acceptors, such as 4-nitrotoluene and 2,4-dinitrotoluene, or electron donors such as N,N-diethylaniline [6] . Thus, photoexcited CQDs are suitable as both electron donors and electron acceptors. On coating the surface with metal dopants, CQDs are also efficient in PL quenching through disruption of the excited state redox processes [56] . Electron transfer was also investigated with nanocomposites of CQDs functionalized with graphene oxide (GO), multi-walled carbon nanotubes (MWNTs), and TiO 2 nanoparticles without linker molecules [57] . Significant PL quenching was observed for the CQD-GO system, which was attributed to the ultrafast electron transfer from CQD to GO with a time constant of 400 fs. In comparison, addition of MWNTs resulted in static quenching of the FL. No charge transfer was observed in either CQD-MWNT or CQD-TiO 2 nanocomposites. These PET properties of CQD electron donors/acceptors may offer new opportunities in photodynamic therapy, light-to-energy conversion-based sensing, drug delivery, as well as a novel route to mechanistic elucidation. Quenching-based PL (on-off, off-on) of CQDs has been developed for sensors targeting biomolecules, metal ions, and toxic substances [16] .
Photomediated energy transfer
Among the various unique properties of nanostructured composites (especially with Au and Ag), an outstanding one is the generation of thermal energy upon photon absorption. Similar phenomena were noted for carbon-based materials [58] [59] [60] [61] . The mechanism of heat generation for atomically thin graphene or CNTs, comprised of free electrons surrounding fixed positive ions, involves electron/light interaction at the interface between the nanosurface and dielectric environment. When irradiated with external light, free electrons collectively oscillate upon light absorption and propagate along the nanosurface as a surface plasmon [62] . On the other hand, when the particle size is even smaller as in graphene QDs or CQDs, surface plasmons cannot propagate but stay within the particle and keep oscillating. This state, called localized surface plasmon resonance, enables light of a resonant wavelength to be absorbed or scattered by the nanoparticle. Thus, light absorption enables heat generation, which can be utilized for the photomediated localized drug delivery and decimation of malignant cells via photothermal therapy, and diagnosis via photoacoustic (PA) imaging.
To enable carbon nanostructures to generate heat inside biological systems, light must penetrate deep into the targeted tissues. Light may encounter several obstacles in its path, such as scattering from or absorption by various biomolecules. In particular, hemoglobin molecules absorb most visible light. On the other hand, NIR light at wavelengths of 650 to 900 nm travels deep into tissues, because hemoglobin and water absorb relatively little light at these wavelengths. Thus, nanoparticle-based agents that can efficiently generate heat with NIR light are favored for photothermal therapy. Strategies to produce CQDs with efficient NIR absorption and emission will be discussed in Section 3.1. The NIR absorption-mediated temperature increase of CQDs has been reported [63] for photothermal ablation therapy for cancer. Using a 671 nm laser (2 W/cm 2 ) with variable CQD concentrations (0-200 μg/mL), the temperature rise of < 4.6 °C obtained with pure water improved with the addition of CQDs to 11.1-26.6 °C after 10 min irradiation (Fig. 4) with a photothermal conversion efficiency of 38.5%.
Hierarchical strategies in engineering CQD probes
The carbogenic core provides a rigid foundation for the development of CQD probes. Manipulation of the core chemical bonding, composition, and size controls the photophysical properties of the probe. However, bare nanoparticles usually cannot interact with biological systems and do not possess any biological functionality. The careful design of coatings, that can encapsulate the CQD core and shield it from the environment, yields biocompatible probes with controllable physicochemical properties. Further decoration Nano Res. 2018, 11(1): 1-41 of the CQDs with biomolecules imparts biofunctionality and bioselectivity, thereby enabling probe interactions with biological systems. Thus, the preparation of CQD-based probes represents a multi-step process, where the stages are guided by the design objectives to control the optical, physical, chemical, and biofunctional properties.
Formation of carbogenic cores
The carbogenic core is at the heart of CQDs, as it provides the optical properties and structural foundation for engineering multifunctional probes. Ideally, CQD cores should be stable with a precisely controlled size distribution, geometry, chemical composition, and surface chemistry. Following the accidental discovery of CQDs during the fractionation and purification of single-walled carbon nanotubes (SWCNTs) [64] , the progress in synthetic procedures enhanced the QY from 2% to about 90% [65] . The synthesis of carbogenic cores is generally classified into "top-down" and "bottom-up" methods. The former involves cleaving or breaking bonds in carbonaceous materials via chemical, electrochemical, or physical techniques to yield sp 2 hybridized carbon atoms with an extended array of conjugated π-electrons [66] . On the other hand, the bottom-up method is realized by pyrolysis or carbonization of small organic molecules, or by the stepwise chemical fusion of small aromatic molecules (Fig. 5) , which generate CQDs with a heterogeneous mixture of sp 2 and sp 3 carbon atoms in varying proportions [67] . In terms of precursors, carbon materials are ideally suited for the macroscale synthesis of carbon dots; however, the use of substantial amounts of oxidizing agents (strong acids) and energy may lead to expensive products and environmental concerns. From this consideration, biomass-based molecules are good alternatives, owing to biomass diversity, the availability of bulk quantities, facile processing, and potential for large-scale synthesis [40] . Detailed discussions on the various synthesis routes are out of the scope of this review and additional details are given elsewhere [68] . Here, we focus on obtaining CQDs that are of significance in designing precise biomedical nanoprobes. A crucial requirement is the synthesis of CQDs having a narrow size distribution. Size-tunable light emission is beneficial for multiplexed molecular labeling and imaging because negligible interference between adjacent emissions enables the simultaneous detection and quantification of multiple FL signals. However, controlling CQD size during synthesis remains a challenge. Four different approaches for size control have been developed: electrochemical synthesis, where the size is controlled by applied potential [69] ; use of polymeric nanoparticle precursors of defined sizes processed under demanding conditions [70] ; templated pyrolysis of organic precursors [71] ; and a stepwise synthesis with organic precursors [72] .
Apart from size control, an increased FL brightness and a wider emission window are equally important for producing CQDs for enhanced bioimaging and deep-tissue probing. Doping of CQD cores with elemental heteroatoms is an effective strategy to generate greater FL, higher QYs, and widely tunable emissions. Heteroatoms are typically inherited from precursors during synthesis. N-enriched amino acids and glucose were used to synthesize N-doped CQDs having a 69.1% QY with a tunable PL, with shorter emission wavelengths obtained with higher N doping Nano Res. 2018, 11(1): 1-41 [73] . This was attributed to the type of N-moieties (mainly pyrrolic, possibly pyridinic, but not graphitic) and the electron-withdrawing ability of N [74, 75] .
The selection of appropriate dopant precursors plays a vital role in controlling the final properties of CQDs. For example, N-CQDs prepared in the presence of 4,7,10-trioxa-1,13-tridecanediamine (TTDDA) possessed a much stronger PL (with QYs up to 33.9%) than those prepared in the presence of dopamine. However, CQDs obtained with dopamine showed better electrochemical activities and pH sensitivities due to the existence of dopamine and dopamine analog electron acceptors [76] . Doping in the carbogenic core framework not only helps to extend the emission window but also widens the absorption spectrum of CQDs. Graphitic nitrogen cores, as compared to pyridinic, pyrrolic, and amino centers, have been shown to have an electron-doping effect that alters the system's electronic energy levels and causes a red-shift in the absorption spectra [77, 78] .
In an era of emerging theranostic applications, the absorption/emission ranges of CQDs preferentially should lie in the first transparent biological window (600-950 nm) since the background noise caused by the absorption/scattering of skin, tissue, blood, and water is low in this range. However, their application in this range is rare [79] because most of the reported CQDs absorb/emit in the visible region. Therefore, the development of an effective method to produce red emissive CQDs may open new paths for biomedical applications, especially in deep-tissue cancer investigations and treatments. Theoretical studies suggested that increasing the particle size to increase the number of conjugated sp 2 -domains favors orange and red emissions. However, large particles usually have large surface areas and hence increased surface defects, leading to inefficient emissions. One report demonstrated a controllable wet surface oxidation method for synthesizing red emissive CQDs centered at 608 nm with a QY of 1.8% [80] . Another group synthesized efficient red emissive CQDs from p-phenylenediamine via a solvothermal method with a PL peak at 603 nm and a 26.1% QY [81] . Use of pphenylenediamine and urea in hydrothermal syntheses combined with column chromatography can produce red emissive CQDs centered at 625 nm with a QY of 24% [24] . The main CQD absorption band can cover blue and green wavelength regions, indicating large conjugated sp 2 -domains. The mechanism for red emissions in CQD spectra is unclear. The authors Nano Res. 2018, 11(1): speculated that large particles with a high nitrogen content may be responsible for the red emission.
Another unique PL feature of CQDs is their multicolored emissions (via single-wavelength excitations). This is potentially useful for applications such as multiplexed PL bioimaging and sensing for simultaneous, multi-element analyses. However, the development of water-soluble, biocompatible, and photostable multicolor emissive CQDs is in its infancy. In this regard, one such work [81] prepared multicolor PL CQDs having red, green, and blue emissions (i.e., the primary colors) by using three phenylenediamines isomers (o-, m-, and p-phenylenediamine) through a solvothermal method (Fig. 6 ). Besides the key optical properties of CQDs, their inherent self-targeting capabilities are important for designing biofunctional probes, e.g., CQDs synthesized via thermolysis with D-glucose and L-aspartic acid as starting materials. The synthesized CQD-Asp exhibited biocompatibility and a continuous full-color emission; in vitro tests also showed a high selectivity and enrichment in brain C6 glioma cells without the aid of extra targeting molecules [82] . Thus, the development of effective methods and theories, together with appropriate precursor materials, may lay the foundations for achieving multi-purpose and customized CQDs with high QYs. The next section shows how controlling surface properties by functionalization and conjugation with biological ligands can hierarchically transform CQDs into biocompatible and biofunctional nanodevices.
Designing biocompatible surfaces
CQDs generally inherit hydrophilicity from their one-step synthesis due to the presence of functionalization such as carboxyl, carbonyl, epoxy, and hydroxyl groups [34] . These synthesized CQDs thereby gain stability, allow photophysical properties, and maintain their size in the quantum range. Furthermore, the outward-facing functional groups facilitate the anchoring of various functional conjugates in the next step of probe design. With a certain level of water solubility and tailored features, the post-treatment of the CQDs with acidic solutions in varying proportions provides a direct way to control the surface state [83] . In addition, the oxidation-mediated procedures that produce low QYs with varying emission profiles preclude the design of precise fluorescent probes. Also, the functional groups within the carbogenic framework can modify the original optical properties by interacting with the surrounding added materials, resulting in a reduced performance.
At the nanoscale, surface functional groups play a major role in determining catalytic, electronic, and optical properties. The surface area to volume ratio increases rapidly as the particle radius decreases, and larger numbers of functional groups reside on the surface. Since the surface chemical groups lack neighbors to form chemical bonds, unoccupied electron orbitals eventuate. Commonly referred to as dangling bonds or surface trap sites, these orbitals can trap charge carriers and either prevent or delay electronhole recombination and the subsequent photon emission, thus reducing FL. To prevent some of these undesirable characteristics, functional group-mediated defects can be saturated by organic and inorganic capping layers. In this case, polymer passivation is often used to improve the QY of CQDs by suppressing the surface emissive traps. The use of PEG, PEI, and Nano Res. 2018, 11(1): 1-41 their derivatives has been reported [84] . The primary amino groups in b-PEI can increase water solubility and cell permeability of the probe for both passivation and functionalization. With a PEG 1500N layer, the QY could reach ~ 75% [85] , double that of the bare counterpart [86] . PEI conjugated onto CQDs through disulfide linkers form positively charged PEI-CQDs, which can electrostatically attach to negatively charged targets [87] . In another approach, the precursors containing primary amines allowed simultaneous N-doping and surface passivation [88] .
Ligand exchange, a widely used strategy to enable nanoparticle grafting, often provides improved nanoparticle stability and also ligands that can be exchanged for new functionalities. In most cases, the incoming ligand molecule binds more strongly to the nanoparticle surface through acylation, carbodiimide chemistry, or salinization of the CQDs. PEG 1500N was grafted onto CQDs via a thionyl chloride reaction, and followed by further crosslinking with dimethyl pimelimidate via acylation for improved stability [89] . Covalent bonding of an imidazole derivative onto the surface of CQDs was achieved per the same principle [90] . Carbodiimide chemistry was used to activate carboxyl groups with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) for coupling with the amine groups of the CQD surface passivation agent. The four-armed amine-terminated PEG provided the covalent amide bonds [91] . In another scheme, thiol groups were introduced on the capping layer of the PEG 200 -passivated CQDs [92] by tethering zwitterionic N-acetyl-L-cysteine and bifunctional mercaptosuccinic acid (MSA) molecules [93] . Two ligand coupling strategies using EDC/NHS (i.e., N-hydroxysuccinimide) was demonstrated on the surface of aminofunctionalized CQDs [94] . CQDs derived from milk were also directly grafted with cysteamine hydrochloride, a stable aminothiol, by a simple mixing process. The amines simultaneously bonded weakly with the hydroxyl groups and covalently with the carboxyl groups; then, the thiol groups underwent further tagging [95] .
Despite the simplicity of the ligand exchange strategy, the attached surface ligands often compromise the FL efficiency, photochemical stability, and shelf life of the probes. Ligands tend to detach from the CQD surface leaving behind surface trap sites, causing nanoparticle aggregation. An efficient ligand exchange approach that forms polymerized silanol shells on CQDs may provide robust probes. Organosilanefunctionalized CQDs were formed via the one-step pyrolysis of anhydrous citric acid in N-(β-aminoethyl)-γ-aminopropyl-methyldimethoxy silane (AEAPMS) [96] . After further processing of the resultant ultrasmall CQDs (0.9 nm) with a high QY (47%), via the silane already present or substitution, a plethora of functional groups were available for covalent attachment. Using the same precursors with a solvothermal method [97] , the bifunctional organosilane was anchored by both ends, leading to long chains with dual functionalization, with -NH 2 or -Si(OCH 3 ) 3 as terminal moieties. In another attempt, (3-aminopropyl)triethoxysilane (APS) and glycerol were reacted in a microwave to generate multifunctional CQDs through simultaneous core formation, passivation, and functionalization [98] .
Surface passivation and functionalization increases the particle size, and could adversely affect quantitative biomarker detection in a crowded biological environment and may deter intracellular penetration. In addition, the reactive groups should be available for conjugating biomolecules with targeting ligands, and CQD probes should display minimized nonspecific interactions with the biological environment. No single method is currently available that satisfies all design criteria based on the demands of biomedical applications, despite the range of surface engineering strategies developed (Fig. 7) . Ligand exchange can often yield compact probes, albeit with reduced stabilities and FL efficiencies, whereas polymer encapsulation produces stable and bright particles at the expense of increased size. Thus, the engineering of coatings that combine all of these essential features with the 
Designing functional bioprobes
Adding biofunctionality to nanoprobes is unavoidable for achieving precise recognition and targeted binding capabilities in various photomediated applications such as bioimaging, sensing, drug delivery, and therapy. Prefunctionalized CQDs can be decorated with biomolecules (e.g., the molecular structures from Ref. [99] shown in Fig. 8 ) such as enzymes, proteins, peptides, lipids, nucleic acids, oligonucleotides, or other biomolecules and functional molecules, such as photosensitizers and delivery molecules, that mediate specific interactions with living systems. Surface engineering is crucial not only for tuning the fundamental properties of CQDs and rendering them stable and transportable in varying environments, but also for creating CQD-biomolecule hybrids capable of probing complex biological phenomena in a targeted manner. Such probes should preserve both optical characteristics and biological functions while operating in a real-life setting. Thus, bioconjugation of nanoparticles has opened up new vistas in nanotechnology over the last two decades [100, 101] .
Bioconjugation strategies can be broadly classified as direct attachment and intermediate coupling types. Direct attachment of bio-or functional molecules generates probes with minimally affected optical properties and sizes. In its simplest form, π-π stacking interactions between dye-labeled single-stranded DNA and the CQD generate a platform to quench the CQD FL. When the target DNA matched the dyelabeled strand to form double-stranded DNA, the FL was recovered [102] . Aptamer biosensors for thrombin detection were also successfully constructed based on π-π interactions between CQDs and fluorescein (FAM) [103] and an up-converting phosphor-labeled aptamer [104] . Electrostatic interactions between the positively charged adaptor protein domain and the negatively charged CQD led to stable deposition of the adaptor on the CQD surface, while the Protein G domain specifically captured the antibody Fc region. The resulting assembly featured precise control over the antibody orientation and eliminated any chemical modification of the immunoglobulin G (IgG) antibody, thus preserving its activity. However, this procedure is often limited to the conjugation of specific classes of ligands (e.g., antibodies). Direct bioconjugation with CQDs is accomplished by covalent bond formation through reactive functional groups, such as primary amines [105, 106] , carboxylic acids [107] , and hydroxyls [108] .
Whilst simple, the direct attachment procedure is often limited by the conjugation of specific classes of functional molecules. Therefore, linker chemicals between CQDs and functional molecules enable bespoke, application-specific customized probes. Chemical approaches to create and add intermediate linkers, involving surface passivation, organic reactions, silanization, etc., have been discussed in previous sections. Here, we note a few functional biomolecules which were tagged after surface engineering steps. For example, protein transferrin was functionalized on passivated CQDs via carbodiimide chemistry for targeting cancer cells. The cellular uptake experiments indicated that the design of surface functional groups permitted efficient conjugation with biomolecules using carbodiimide agents [91] . An amino-modified aptamer was conjugated with carboxyl-modified CQDs through EDC/NHS coupling for 1 h with gentle stirring in the absence of light [109] . In one study [87] , negatively charged short interfering RNA (siRNA) was electrostatically complexed with PEI-grafted CQDs conjugated with folate, a tumor targeting agent, to produce multifunctional nanoagents for in vitro and in vivo investigations. Nano Res. 2018, 11(1): 1-41
The choice of bioconjugation depends on the availability of molecules having suitable functional groups and specific application requirements. Common design criteria involve preserving the CQD photophysical properties, linker biofunctionality, ligand orientation and binding stoichiometry, compact probe size, and its stability in physiological environments. As the satisfaction of these criteria is limited, the improvement of existing bioconjugation techniques, and the design of novel application-specific water solubilization and bioconjugation approaches, remain active areas of research. With the development of stable biofunctional CQD probes, these materials can be offered as multifunctional platforms having flexible properties that can be further optimized for a range of applications.
Advances in photomediated diagnostic and therapeutic applications
The stepwise surface design and bioconjugation of carbogenic cores can help CQDs probe complex cellular and extracellular structures and processes in both in vitro and in vivo settings. Therefore, customdesigned CQD probes have potential in a range of bioapplications, such as the histological evaluation of cells and tissue specimens, long-term live-cell imaging, the study of biological processes, single molecule detection, and real-time tracking.
CQDs in photomediated diagnostics

Pathological marker sensing
The common diagnostic approach is to detect substances in the blood or other body fluids that correlate with the presence of specific diseases. These disease markers take the form of proteins, carbohydrates, nucleic acids, or concentration thresholds of elemental regulating factors associated with disease states. Measuring the levels of particular biomarkers in a patient's blood, urine, feces, or saliva helps to detect disease stages, identify inflammation, predict risk, and monitor the therapeutic efficacy of administered treatments. Among the methods of biomarker analysis, FL-based optical modalities that detect such molecular signatures have become pivotal tools because of their high sensitivity and spatial resolution. Immunohistochemistry (IHC) and FL in situ hybridization (FISH) techniques are used in pathology to detect protein and nucleic acid biomarkers within cells and tissue specimens. In this regard, CQDs act either as stains for highlighting cell structures or as specific probes for labeling biomarkers.
The most common design of assemblies used for detecting biomarkers is a sandwich-type assay that is comprised of several components: a substrate, capture antibody, analyte of interest (biomarker), second capture antibody, and a secondary antibody usually tagged with a fluorescent probe. With such an assay, the immobilized monoclonal primary antibody binds to the biomarker. Next, a second capture antibody, specific for the biomarker, is introduced to sandwich the target. A secondary antibody, usually fluorophorelabeled, binds to the second primary antibodyand generates a fluorescent signal, detectable via microscopy or FL spectrophotometry. These sandwich-type assays have high specificity due to the affinity and selectivity of primary antibodies for their analyte. They also have a high sensitivity when CQDs are used as fluorescent labels for the secondary antibody due to the strong FL signal from CQD-conjugated antibodies. Sandwichtype assays can be conducted both on a substrate and free in solution. Suspension assays in solution are advantageous because they exhibit faster kinetics than assays performed on a substrate, allowing faster readouts and higher sample throughputs [110] . These homologous assays can be easily tailored for detecting various analytes, and do not require optimization of the immobilizing antibodies and antigens or extensive washing steps to separate the bound and unbound moieties. One example of a homogeneous in-solution assay, based on the CQD FL enhancement that arises from antibody-antigen interactions, involved the use of carboxylated CQDs grafted with a goat antibody (gIgG) using EDC/NHS amidization followed by incubation with human IgG (the antigen). The immunocomplex of gIgG-IgG formed on the surface of the carboxylated CQDs resulted in increased FL. A linear relationship between the FL change ratio and human IgG concentration was established with a detection limit of 0.01 mg/mL. This immunoassay was applied to determine IgG levels in human serum, with recoveries of 95.8%-111.5% [111] .
One type of fluorescent nanoparticle-based immunosensor consists of either an analyte or a captive antibody immobilized onto a surface, which is commonly composed of glass, silicon, or gold. Unlike homogeneous in-solution immunoassays, these heterogeneous sandwich-type immunosensors require small amounts of sample from the patient and can provide rapid high-throughput analyte detection [112] . Relating to this, a well plate-based immunosorbent assay was developed to detect human α-fetoprotein (AFP) using CQDs (Fig. 9) . First, the CQDs were used to label one member of the anti-AFP pair (Ab 2 ) via amine−amine coupling using glutaraldehyde. The capture agent, anti-AFP (Ab 1 ), was coated onto polystyrene well plates, within which the AFP was then incubated. Next, the Ab 2 -labeled CQDs were added to form sandwiched immunocomplexes with the AFP bound to the Ab 1 -coated wells. The FL intensities positively correlated to AFP concentration in the clinically relevant range of 0−350 ng/mL. This was in agreement with the results from two traditional high-throughput immunosorbent assays: the fluorescein isothiocyanate or FITC-linked immunosorbent assay (FLISA) and colorimetric enzyme-linked immunosorbent assay (ELISA) with horseradish peroxidase (HRP). These results indicated that CQDs have potential as biolabels for highthroughput well plate-based immunoassays [113] .
An efficient, paper-based sandwich immunoassay device demonstrated on Whatman filter and nitrocellulose papers was developed for the detection of the human immunodeficiency virus-1 (HIV-1) p24 antigen using CQD as the fluorescent marker. The primary (capture) antibody was immobilized on the patterned paper through physical adsorption; varying antigen concentrations were then added to the wells. Subsequently, a biotinylated secondary (detector) antibody solution was dropped onto each well, and followed by the addition of streptavidin-conjugated CQDs. The detection range of 0.01 to 1 ng/mL for the Whatman filter paper was lower than that of the nitrocellulose paper (10 μg/mL to 250 pg/mL). The nitrocellulose paper exhibited four-times higher sensitivity and reduced the assay time three-fold compared to the Whatman paper. HIV-negative and HIV-positive plasma samples were tested for the detection of HIV-1 p24. Both immunoassay types exhibited no false positive or negative results with recovery rates near 100%. This simple and sensitive CQD-based paper immunoassay may be useful in preventing HIV transmission through blood transfusions in resourcelimited areas of the world [114] .
Employing FRET principles in a homogenous immunoassay, an immunosensor has been proposed [115] for the quick and specific detection of 4,4'-dibrominated biphenyl (PBB15), a persistent organic pollutant that disturbs the endocrine system. CQDs were labeled with a PBB15 antigen (PBBAg) while gold nanoparticles (AuNPs) were modified with an anti-PBB15 antibody (anti-PBBAb). The specific combination of the functionalized CQDs and AuNPs led to significant quenching of the CQD PL due to FRET. However, PBBAg-CQDs could be partly displaced from the anti-PBBAb-AuNPs by PBB15 due to the competitive immunoreaction, recovering the PL signal. The increased PL intensity was proportional to the concentration of PBB15 in the range of 0.05-4 μg/mL, with a detection limit of 0.039 μg/mL.
The immunoassay-based detection of extracellular protein markers may not always allow the identification of subpopulations of cancerous cells that do not express the surface marker of interest [116] . Therefore, the profiling of cancer cells based on intracellular genetic content as the recognizing element, such as oligonucleotides, was used. CQDs obtained from citric acid and passivated with PEG 8000 successfully detected double-stranded DNA (dsDNA) through PL enhancement due to the formation of hydrogen bonds between the CQDs and dsDNA, while the singlestranded DNA (ssDNA) did not interfere [117] .
MicroRNAs (miRs) are recognized as regulators of the gene expressions related to cellular development and diseases. A representative CQD-based miR124a molecular beacon (miR124a CMB) was developed [118] . Upon incubation with P19 cells, the miR124a-which is highly expressed during neurogenesis-bound to the miR124a CMB binding sites, resulting in the detachment of the quencher from the CQD and hence FL recovery.
Target-induced assembly of a sandwich nanostructure has been demonstrated in the fluorescent CQD-based detection of thrombin [119] . Two thrombin aptamers were individually coated on the surfaces of CQDs and silica nanoparticles to produce two separate assembly units. In the presence of thrombin, the smaller CQD units attached to the surfaces of the larger silica nanoparticles due to the specific aptamer-thrombin interactions. After centrifugation and re-dispersion, the sandwich-structured product was quantitatively detected by FL emission spectroscopy, through which the amount of thrombin was quantified.
PEI-passivated CQDs were reported as a nanogene vector to condense double-stranded plasmid DNA (pDNA) and mediate its transfection into COS-7 and HepG2 cells; up-regulation of the marker gene expression was exhibited over naked DNA [120] . Inspired by the intriguing enhanced PL of N-doped CQDs and the progress in understanding carbon nanotubes (CNT)-DNA interactions, the FRET process was used to explore whether functionalized CQDs can change the DNA structure and facilitate such transitions, especially the B-Z transition [121] . A CQD-aptamer hybrid was proposed as a fluorescent probe for the quantitative detection of one of the most common foodborne pathogenic bacteria, Salmonella typhimurium. Carboxyl-modified CQDs were activated by EDC/NHS, and then conjugated with aptamer amino groups to form CQD-apt complexes (Fig. 10) . The detection process was complete within 2 h and sensed up to 50 cfu/mL (i.e., colony-forming units per milliliter); a linear relation between FL intensity and bacterial concentration was established (10 3 to 10 5 cfu/mL). Furthermore, bacteria diluted in an eggshell and tap water mixture were detected by the conventional plate count method [109] .
A FRET-based CQD-DNA biosensor was developed using an aptasensor platform for the quantitative monitoring of adenosine 5′-triphosphate (ATP) by the interaction of dispersed/agglomerated AuNPs with terbium ion-coordinated CQDs (Tb-CQDs). Upon introduction of the target, the aptamers bound with the analyte to form new aptamer-ATP complexes Nano Res. 2018, 11(1): 1-41 that coated the surface of the AuNPs to inhibit their aggregation in the high-concentration salt solution. In this case, the fluorescent signal of the Tb-CQDs was quenched by the dispersed AuNPs through FRET. In the absence of the target analyte, the AuNPs tended to aggregate in the high salt concentrations even if aptamers were present. Thus, the added Tb-CQDs maintained their intrinsic fluorescent intensity. This hybrid system exhibited good fluorescent responses towards ATP in the dynamic range of 40 nM to 4.0 μM with a detection limit of 8.5 nM. Additionally, the response was found to be acceptable with other triphosphates. On applying this method to real human serums, the recovery of ATP was found to be 97.0% to 103.7% [122] .
Apart from immunological-and DNA-based techniques, an alkaline phosphatase (ALP) enzymetargeting optical biosensor was reported using CQD nanoprobes through specific host-guest recognition using the PET mechanism [123] . CQDs were first functionalized with 3-aminophenylboronic acid to produce boronic acid-functionalized CQDs, and then further modified with hydropropyl β-cyclodextrins (β-CD) through B-O bond formation to form β-CD-CQD nanoprobes. The p-nitrophenol phosphate disodium salt was used as the ALP substrate, and was hydrolyzed to p-nitrophenol (PNP) under the catalytic effect of ALP. The resulting PNP could enter the cavity of the β-CD-CQD nanoprobe due to its specific host-guest recognition, where PET between the PNP and CQD took place to efficiently quench the FL of the probe, as shown in Fig. 11 . The correlation between quenched FL and ALP level was used to quantitatively evaluate ALP activity over a broad range from 3.4 to 100.0 U/L (i.e., units per liter) with the detection limit of 0.9 U/L. This assay showed a high sensitivity to ALP even in the presence of a very high concentration of glucose.
Alternative optical sensing-based fluorescent assays that use the inner-filter effect (IFE) have been constructed using CQDs, since this effect does not require the complex tuning of the quencher (or receptor) and fluorophore separation to realize electron or energy transfer, a key part of optical sensing via FRET, PET, electronic energy transfer (EET), and intramolecular charge transfer (ICT). A CQD-based IFE fluorescent assay was developed [124] to sense ALP in buffer solutions and living cells, where the CQD acted as an IFE fluorophore and the ALP hydrolysate as an IFE absorber. This method was shown to be facile and sensitive with simple consumption, and provides a potential platform for ALP sensing in clinical diagnoses and trace ALP inhibitor screening in drug discovery. In a follow-up [125] , an IFE assay was developed for determining the tumor invasive biomarker β-glucuronidase (GLU). N-doped CQDs with a green PL were used as fluorophores for the IFE. Also, 4-nitrophenyl β-D-glucuronide (PNPG) served as the GLU substrate, and PNP-the catalytic product of GLU-acted as a robust absorber in the IFE to turn off the N-CQD FL due to the complementary overlap between the PNP absorption and the N-CQD excitation, as shown in Fig. 12 . This system showed a good linear relationship for GLU concentrations from 1 to 60 U/L with a low detection limit of 0.3 U/L.
Besides these representative CQD-based specialized optical biosensing applications, other pathological markers have also been coupled with PL quenching, Nano Res. 2018, 11(1): 1-41 enhancement, and energy or electron transfer between surface-engineered CQDs. Examples include DNA [126] , ATP [127] , histidine [128] , ALP [124] , ascorbic acid [129] , tyrosinase (TYR) [130] , dipicolinic acid (DPA) as an anthrax biomarker [131] , blood sugar [132] , H 2 O 2 [133] , Cu ions [134] , glutathione [135] , and Escherichia coli [136] .
Targeted cellular and extracellular bioimaging
Imaging based on CQD FL is an attractive technique for the visual evaluation of phenotypes of healthy and diseased cells, as well as molecular signatures of diseases both in vitro and in vivo. Being simple and inexpensive compared to other molecular analyses, imaging is a powerful tool for studying complex intracellular organelles and physiological chemicals, and evaluating the pharmacokinetics and biodistributions of targeted CQD-based probes in a wholeanimal context. Thus, CQDs have potential as probes for in vitro molecular profiling of cells and tissues, and as cell tags and vasculature contrast agents for in vivo imaging. However, CQD-based targeted imaging remains a challenge due to the lack of penetration within the crosslinked intracellular compartments of fixed cells, especially membrane-bound compartments, such as nuclei and mitochondria. It also lacks specificity in heterogeneous physiological conditions and experiences the pervasive foreign-particle clearance mechanisms under in vivo conditions. Therefore, research focus is well-placed on the engineering of specific functionalities that exploit passive CQD accumulation within a cell or tumor via enhanced permeability, retention, and active targeting (i.e., an antibody-coated CQD binding to a specific cancer cell membrane antigen) without compromising on biocompatibility, extravasation, and blood circulation. Most bioimaging that relies on CQD uptake is undertaken via passive targeting, which only stains the easily accessible cell membrane and cytoplasm over other compartment-protected organelles such as the nucleus [137] [138] [139] [140] . However, clinically relevant and more efficient active targeting could offer durable, higher contrast imaging [141] , and this is yet to be addressed.
Transforming CQDs into targeted molecular imaging probes requires specific binding to the receptor, such as through antibodies, proteins, peptides, and nucleotides. Integrins are cell adhesion molecules that are overexpressed during tumor growth and metastasis, and cyclic Arg-Gly-Asp (RGD) peptides are known to bind to α v β 3 integrins. CQDs coated with the RGD peptide were therefore delivered for the in vivo imaging of HeLa tumor cells. The accumulation of CQDs both on the cell membrane and in the cytoplasm was visualized, indicating α v β 3 integrin receptor-mediated endocytosis of the RGD-CQDs (Figs. 13(a)-13(c) ). In contrast, no FL signal from α v β 3 -negative MCF-7 cells was detected ( Fig. 13(d) ) after incubation with CQDs, suggesting specific targeting of RGD-CQDs towards live cells [142] .
Similar results were obtained when RGD-Gd@CQDs, formed with EDC/NHS coupling, were applied on U87MG cells [143] . Twin-arginine translocation (TAT) peptide-or folate-conjugated CQDs showed improved cellular uptakes compared to unconjugated CQDs [144] . In another study, EDC/NHS crosslinked TAT-CQDs Nano Res. 2018, 11(1): 1-41 [145] were used as single-particle tracking probes on a living cell membrane (Figs. 14(a)-14(c) ) to track diffusion trajectories (Figs. 14(d)-14(g) ).
Selective cancer cell bioimaging using maleimideterminated TTA1 aptamer-conjugated CQDs showed that Tenascin C (Tnc) proteins were highly expressed in HeLa cells and C6 cells, but rarely expressed in CHO (Chinese hamster ovary) cells. TTA1-CQDs were found to be significantly selective towards HeLa and C6 cells with negligible acceptance by CHO cells [146] . A growing number of humanized monoclonal antibodies are available against tumor-specific cell surface antigens and epitopes; these are now used in cancer therapies. Thus, molecular imaging with antibodies has great potential to detect and characterize cancers. PEI-CQDs were used to examine the FL labeling of HeLa cells; the CQD-CEA8 antibody conjugates were visualized by the green FL contour of the cell shape, whilst no bare CQDs were visible under UV excitation [147] .
Phospholipid-conjugated CQDs have recently been used for studying lipid dynamics in cell membranes. The CQD-mediated FL images captured information on lipid mobility, bilayer fluidity, and the lateral diffusion processes in the membrane bilayers. Hence, this CQD-lipid conjugate has emerged as a versatile tool for membrane studies, extending such FL-based studies of membrane dynamics [148] .
Insulin-conjugated CQDs were used to reveal the real-time dynamics (distribution, internalization, and recycling) of insulin receptors in adipocytes. This study discovered that internalization and recycling of insulin receptors in adipocytes were oppositely regulated by apelin and TNF, the tumor necrosis factor. This finding helps us understand how these cytokines regulate insulin sensitivity, through the aid of CQDs as fluorescent tags for real-time molecular imaging of live cells [149] .
Use of targeting ligands (antibodies, peptides, other biomolecules) on CQDs is a facile route to selective bioimaging, and an extensive library of such molecules is widely available. However, the significant increase in probe size, challenge of target tethering, and potential immunogenicity of foreign proteins puts this approach under scrutiny. Therefore, the engineering of compact non-immunogenic CQD probes remains highly attractive. CQDs that targeted brain cancer gliomas without the aid of additional molecules were developed by using L-aspartic acid as the starting material. Compared to the probes synthesized using other precursors, in vivo FL images showed a highcontrast biodistribution and much stronger FL in the glioma sites than that in normal brain tissue, indicating their ability to freely penetrate the blood-brain barrier. Thus, the selection of an appropriate precursor can yield CQDs with excellent targeting attributes.
A recent study on two cell lines demonstrated that neutrally charged blue emissive CQDs selectively stained the cell nuclei. This suggested that controlling the surface electric charge can allow imaging of intracellular organelles in a targeted manner [150] . Dopamine-derived N-CQDs were found to act as direct nuclei-targeting vectors for different cell lines. The dopamine-mimicking groups on the N-CQDs ''tricked'' the nuclear membranes to allow their entry into the nuclei [151] .
External factors (mode of excitation, pH) also influence specific cellular imaging. Multi-photon irradiation of CQDs can provide details on specific intracellular organelles through FL imaging compared to one-photon imaging. In Figs. 15(c) and 15(d), twophoton bright-field and FL images show that CQDs can label the cell membrane, cytoplasm, and nucleus of each HeLa cell. However, poorly defined patterns are observed (Figs. 15(a)-15(b) ) with one-photon imaging [152] .
The role of pH in specific cellular bioimaging was reported with P-and N-doped CQDs (P,N-CQDs) in live MCF-7 cells yielding variable intracellular information [153] . At pH 7.4, the CQDs were welldispersed and the cytoplasm region between the nucleus and the cell membrane was clearly visible. When the pH was decreased to 4.7, the yellow cytoplasmic region was blurred (Figs. 16(b) and 16(h) ) and at 1.5, the cytoplasm and nucleus regions were hardly distinguishable (Figs. 16(c) and 16(i) ). However, the yellow emission was recovered when the pH was switched back to 7.4, demonstrating the reversibility of the P,N-CQD emission. Similar pH-dependent bioimaging was also demonstrated with pathogenic fungal cells [154] and HeLa cells [130, 155] .
Other than different organelles, the molecular elements in the intracellular environment can be selectively imaged and monitored using CQDs. For instance, covalently immobilized europium complexes on CQDs have enabled the sequential detection of two targets, tetracycline (Tc) and H 2 O 2 , in live cells. The in situ-generated CQD-DTPA-EuTc was nonemissive, but an intense red luminescence was observed upon addition of H 2 O 2 . Highly reproducible results were obtained in Plat-E cells, demonstrating the identification of Tc and H 2 O 2 in cellular environments Nano Res. 2018, 11 (1): 1-41 with high accuracy [156] . CQD-mediated imaging of Hg 2+ in Hep-2 cells was demonstrated with varying concentrations of Hg 2+ to semi-quantitatively visualize and monitor the intracellular ion levels. The FL signal gradually decayed with the increase of Hg 2+ concentration. The laser confocal microscopy images were consistent with the quantitative analysis of the FL intensity [157] . Similarly, image-based selective detection and quantification of Fe 3+ in live intracellular environments was reported [142, 158, 159] .
Besides CQD-mediated intracellular imaging, realtime extracellular imaging of components and their surroundings (such as tissue, organ, full body, vasculature, and species in the extracellular matrix) with CQDs is equally important. This would allow us to improve our understanding of extracellular physiological and pathological processes for clinical diagnostics and therapy. A common extracellular application of QDs is FL-contrast imaging of the blood vasculature and lymphatic drainage systems [160] . Intravenously injected fluorescent nanomaterials can highlight morphological abnormalities in vasculature, model the biodistribution of nanoparticle-based drug delivery vehicles, and monitor blood circulation dynamics. In contrast, intradermally delivered fluorescent probes can map the lymphatic basins along with sentinel lymph nodes (SLN), and uncover diseaserelated transport mechanisms (e.g., tumor metastasis pathways). The multicolored nature of CQD probes may help investigate separate vascular systems in a multiplexed manner to provide insights into the intricate blood and lymph circulation networks within organs and tissues.
In clinical practices, the ability to map tumor vasculature and lymphatic drainage pathways could enhance diagnostic accuracy and provide intraoperative image guidance for effective noninvasive tumor and lymph node resections. However, the deployment of CQDs in these applications is in its infancy. In one instance, CQD-Asp [82] , having a high biocompatibility and continuous full-color emission, was shown to have a high selectivity and targeting ability towards C6 glioma cells. In vivo imaging confirmed that CQD-Asp can localize into glioma sites with a much higher intensity (Fig. 17) than normal brain tissue. This indicates its efficacy as a targeted imaging agent for brain gliomas, and potential as a platform for intelligent nanomedicine. The targeting function of CQD-Asp possibly originates from the RGD-like functional groups on the CQD that formed during preparation from D-glucose and L-Asp. RGD-like groups result in the high glioma targeting efficiency of CQD-Asp.
CQDs in photomediated therapeutics
Bioimaging and therapeutic delivery
Apart from diagnosis, CQDs can mediate therapy through the carriage, targeted release, and monitoring of therapeutic agents. Therapeutic delivery systems (TDSs) can enhance the efficacy of pharmaceutical payloads [161] and improve drug solubility, stability, biodistribution, and pharmacokinetics. In current TDS, CQDs are mainly categorized as carrier platforms to conjugate therapeutic agents or as fluorescent tags with a capsule-like carrier. So far, metal-based fluorescent QDs have been extensively used to create optical image-guided TDSs to follow therapeutic molecules noninvasively in real time in live organisms [162] . However, due to concerns about their highly CQD-based TDS designs in use are schematically shown in Fig. 18 . In the first method, CQDs are co-loaded as fluorescent tags with drugs ( Fig. 18(a) ) and genes in polymer/protein matrices. For example, anionically-terminated luminescent CQDs combined with cationic acetylated G5 poly(amido amine) (G5-Ac85) dendrimers via noncovalent interactions to form self-assembled fluorescent hybrids, as shown in Fig. 18(a) . The FL and lifetime of the CQD hybrids was enhanced in the vicinity of the primary amine groups of the dendrimers, making them suitable as cellular imaging probes. Encapsulation of the chemodrug epirubicin (EPI) in the dendrimer interiors transformed them into multifunctional CQDs@EPI G5-Ac85 hybrids. These served as a dual-emission delivery system to track the intracellular distribution and cytotoxic effects of EPI towards breast cancer cell (MCF-7) apoptosis ( Fig. 18(a) ) [163] .
Similarly, CQDs were embedded in situ in chitosan matrices followed by electrostatic conjugation with the poorly water-soluble drug telmisartan (TEL) for concurrent optical imaging and intracellular drug delivery [164] . To increase efficacy, disease site-specific drug delivery is required. This can be achieved through a receptor-mediated endocytosis pathway. This delivery can be accomplished by conjugating a drug-delivery vehicle with an acceptor molecule that specifically recognizes the receptor on the surface of the target cells. To achieve targeted cell imaging and delivery, folate is often used as an identifier due to its high expression in most cancer cells [165] . CQDs were embedded with bovine serum albumin (BSA), which was followed by the attachment of doxorubicin (DOX). The release profile of DOX was studied using standard statistical models and confirmed as first order at pH 7.2. Cellular imaging was performed with epifluorescence microscopy, which showed bright green FL due to the internalization of the CQDs to target the folate-receptor overexpressing HeLa cells in vitro [165] .
Tagging CQDs on hard materials, such as mesoporous silica nanocarriers (MSNs), was reported in relation to image-guided targeted drug delivery. CQDs were tagged in situ on MSNs during the calcination of the surfactant cetyltrimethylammonium bromide. The surfaces were then serially modified with C=C bonds and thiol derivatives to endow switchable zwitterionic surfaces and enzyme-responsive drug release properties. The persistent blue FL was shown to effectively track preloaded drugs and label target cells. The switchable surface property (electrically neutral at pH 7.4, positive at pH 6.8) and enzyme (esterase)-triggered drug release allowed a prolonged blood circulation time with zero premature release, efficient cellular uptake, and intracellular drug release, which are significant for targeted drug delivery. These results indicate that CQD-tagged MSNs have potential for the improved therapeutic delivery of cancer treatments [166] .
CQD fluorescent tags were also applied in gene therapy, where the transfection of pDNA was monitored via the PL of CQDs paired with AuNPs. Firstly, CQDs and AuNPs were electrostatically distributed in PEI, Figure 18 Use of CQD in therapeutic-delivery systems: (a) as a tag with another carrier [163] and (b) as a self-carrier [168] . Reproduced with permission from both Refs. [163, 168] , © the American Chemical Society 2015, 2016. Nano Res. 2018, 11(1): 1-41 a cationic polymer. The subsequent treatment with non-labeled pDNA gave a quenched ternary CQD-PEI/ Au-PEI/pDNA delivery nano-assembly. High salt concentrations triggered the dissociation of the complex. The resulting FL recovery, which arose due to the increased distance between the CQDs and AuNPs, was measured and imaged at the intracellular level during transfection at the post-endosomal step [167] .
In a second method, CQDs performed as the scaffold (Fig. 18(b) ) and FL tracer for therapeutic molecules. An extracellular microenvironment-responsive drug nanocarrier based on CQDs was developed for image-guided drug delivery. CQDs were conjugated with a cisplatin(IV) prodrug (Pt(IV)) by EDC/NHS amidation between the CQD amino group and the carboxylic acid group of the Pt(IV) prodrug. Negatively charged PEG-(PAH/DMMA) was electrostatically complexed with the positively charged CQD−Pt(IV) particles to form CQD−Pt(IV)@PEG-(PAH/DMMA). The positively charged nanocarrier displayed a high affinity to the negatively charged cancer cell membrane, which resulted in enhanced internalization and effective activation of the cisplatin(IV) prodrug in the reductive cytosol than under normal physiological conditions. The non-charge-convertible nanocarrier was observed using in vitro confocal laser scanning microscopy (CSLM). In vivo experiments further demonstrated the high tumor-inhibition efficacy and few side effects of the charge-convertible CQDs, indicating their ability to act as smart drug nanocarriers with potential for clinical application in cancer treatments [168] .
A recent report described the direct attachment of digitonin (DG), a well-known cell membrane permeabilizing agent, on the CQD surface with further conjugation of the anticancer drug methotrexate (MX). The in vitro drug release profile of MX in C6 glioma cells from this CQD scaffold ensured a safe intracellular drug delivery, confirmed by confocal imaging [169] .
Drug release was monitored using reversible donorquenched energy transfer. When DOX, the energy receptor, was electrostatically loaded onto the donor CQDs, FL was instantly inhibited, and resumed after DOX was released from the surface through endocytic uptake, as schematically presented in Fig. 19 . Most DOX molecules were released from the CQDs after 6 h incubation and entered the cell nuclear region after 8 h, suggesting that the drug delivery system may have potential for the visible sensing of drug release [170] . Cow milk-derived N-doped CQD surfaces were attached with cysteamine hydrochloride (Cys) linkers to anchor the anticancer drug berberine hydrochloride (BHC). This formed the 88% BHC-loaded CQD@Cys-BHC delivery complex. The successful drug delivery (therapeutic) and bioimaging (diagnostic) properties of the CQD@Cys-BHC complex were monitored in HeLa cervical cancer and breast cancer (MDA-MB-231) cells by CLSM and FL microscopy [95] . Similar applications of CQDs as drug carrier scaffolds and FL tracers have been reported [171] [172] [173] [174] .
CQDs are also suitable as bright carriers of gene molecules. In a recent report, alginate-derived positively charged CQDs showed a low cytotoxicity and the ability to condense macromolecular DNA upon their simple electrostatic interaction. The photoluminescent CQDs tracked their own cell entry paths, thereby simultaneously playing dual roles as both the non-viral gene vector and bioimaging probe [175] . Besides the direct CQD/DNA interactions, surface-engineered CQDs with conjugated gene ensembles exhibited excellent water dispersibilities, biocompatibilities, high QYs, and intracellular uptakes in simultaneous gene delivery and bioimaging applications [120, [176] [177] [178] [179] .
CQDs have been used as luminescent hollow spheres, opening a simple means to design dual-mode imaging and drug delivery platforms. Hollow CQDs (HCQDs) with an average pore size of ~ 2 nm and QYs of 7% allowed cellular imaging and the delivery of DOX. The intracellular internalization of the DOX-HCQD delivery system and the pH-controlled release were studied through the PL of the HCQDs. Thus, the single CQD-based platform can be used for both cell imaging and cancer therapies [180] . In contrast to passive therapeutic carriers, CQDs can provide active therapeutic functions, such as a drug-like inhibitory effect on cancer cells. CQDs from used green tea were effective inhibitors against breast cancer cells through apoptosis. Relative to catechin, the CQDs had higher inhibition efficiencies for MCF-7 and MDA-MB-231 cells, with a greater biocompatibility and safety. The presence of intrinsic PL, low toxicity, and cancerinhibition properties allowed in situ locating of CQDs in mice bodies, while monitoring cell secretion and inhibition during the growth of cancer cells via optical images [181] . The CQD-mediated inhibitory effects were characterized through PL imaging of E. coli [182] and diseases caused by peptide or protein fibrillation processes [183] .
A CQD-based photoresponsive nanodrug delivery system was constructed using quinolone; the strong fluorescent properties of the CQDs were explored for in vitro cellular imaging. The photo-triggering ability of quinolone (Qu) was exploited for the efficient release of chlorambucil (cbl), an anticancer drug, using one-photon excitation. Further, Qucbl-CQDs were readily internalized inside HeLa cells and showed precise control over the drug released to kill cancer cells on irradiation. This work was extended to an in vivo setting by using the up-conversion property of CQDs in the NIR region [184] .
Photodynamic therapy
PDT involves clinical tumor treatment using lightgenerated cytotoxic singlet-state ROS [185] . This treatment was recognized as having minimal invasiveness and toxicity. Typical PDT treatments involve three components: the photosensitizer, light source, and oxygen within the tissue at the disease site, as schematically shown in Fig. 20 . Under an appropriate excitation wavelength, the photosensitizer is excited from a ground singlet state ( 1 O 2 ) to an excited singlet state, and undergoes intersystem crossing to a longer-lived excited triplet state. The excited triplet photosensitizer reacts with an oxygen molecule, resulting in highly cytotoxic ROS [186] . These chemical species can effectively kill cancer cells by breaking various cellular compartments through the concomitant cell apoptosis or necrosis. However, visible light has a weak tissue penetrability, and PDT sensitizer molecules have poor tissue targeting properties. Broad-wavelength excitable CQDs with tunable upand down-conversion properties are a promising energy donor and carrier for these sensitizers. Greenlight-emitting CQDs were conjugated to the photosensitizer Ce6 to improve their biocompatibility and light emission intensity [187] . The composite allowed simultaneous imaging and in vivo PDT of tumors; however, the PDT efficiency was dominated by Ce6 and limited to shallow tissue investigation and low cell cytotoxicity due to excitation within the UV Nano Res. 2018, 11(1): 1-41 regime. Therefore, another CQD-protoporphyrin(IX) sensitizer conjugate was designed [188] to exploit the large two-photon absorption cross section of CQDs. This enabled indirect excitation of the sensitizer with 800 nm irradiation via FRET, which showed the potential of CQDs in the treatment of deep-seated tumors by PDT. Considering the limited in vitro PDT efficiency of CQDs, owing to the low 1 O 2 QY and short PL lifetime of the adjacent photosensitizer, large quantities of highly water-dispersible CQDs were prepared from polythiophene derivatives [189] . The CQDs produced 1 O 2 via a multistate sensitization (MSS) process, resulting in a QY yield of > 1.3 (the highest value reported for photosensitizers), and a broad absorption band spanning the UV and visible parts of the spectrum (400-700 nm), with a strong deep-red emission. The in vitro and in vivo studies showed that this CQD could be a new type of PDT agent with simultaneous imaging and cancer ensemble destruction capabilities. The PDT agent was claimed to possess a superior performance relative to conventional agents in terms of 1 O 2 QY, water dispersibility, photo-and pH-stability, and biocompatibility. In addition to cancer cell destruction, the PDT agent destroyed common disease-causing gram-negative and gram-positive bacteria [190, 191] .
Hypoxia, a typical feature of solid tumors, remarkably restricts the efficiency of PDT. Recently, CQDs and a polymer-modified carbon nitride (C 3 N 4 )-based multifunctional nanocomposite (PCCN) for light-driven water splitting were used to solve this problem. CQDs were first doped with C 3 N 4 to enhance its red light absorptions as this could be used to trigger in vivo water splitting. A polymer containing a protoporphyrin photosensitizer, a PEG segment, and a targeting RGD motif was synthesized and introduced to CQD-doped C 3 N 4 nanoparticles. An in vitro study showed that PCCN could increase the intracellular O 2 concentration and improve the ROS generation in both hypoxic and normoxic environments upon light irradiation. Cell viability assays demonstrated that PCCN fully reversed hypoxia-triggered PDT resistance with a satisfactory inhibition of cancer cell growth in 1% O 2 . In vivo experiments indicated that PCCN had a superior ability to overcome tumor hypoxia. The use of such water splitting materials shows potential to improve intratumoral oxygen levels and reverse the hypoxia-triggered PDT resistance. PCCN down-regulated the hypoxia-associated proteins and inhibited tumor metastasis. As an endogenous route to produce O 2 with a high efficiency, the water splitting strategy presented great potential for enhancing clinical therapies [192] .
Photothermal therapy
PTT is a strategy to treat medical conditions by IR radiation [193] . The basic model is derived in part from PDT by utilizing the photosensitizer-released vibrational energy (heat) to kill cells [194] . Noble metal nanoparticles have been successfully used in this application due to their large absorption coefficient over a wide spectral region. The large numbers of mobile π-electrons in CQDs lead to relatively strong electron−electron scattering and weak electron−phonon interactions. It was speculated that these CQD π-electrons act similarly to the free electrons in metallic nanoclusters rather than inorganic semiconductor QDs [8] . The limited QYs of CQDs means most absorbed light is eventually converted into heat through several non-radiative relaxation pathways. This suggests their potential for use in PTT.
Using a top-down approach [195] , carbon fiberderived CQDs were formed that were activated upon NIR laser irradiation (670 nm). Irradiation enabled the electron cloud formation, thereby generating sufficient heat (> 50 °C ) to kill ~ 70% of cancer cells by thermal ablation, as compared to control groups in both in vitro and in vivo studies. CQD PTT agents were also synthesized as [196] from dopamine through a bottom-up method, without surface engineering, Nano Res. 2018, 11(1): with an average diameter of ~ 23 nm. The synthesized CQDs dispersed in aqueous media exhibited a high PT conversion efficiency (35%) and killed cervical tumor cells (HeLa) upon laser irradiation (808 nm); no appreciable cytotoxicity was observed even at high concentrations. In another approach [197] , a supraassembly approach was shown to overcome the limited light absorption of CQDs in low-energy spectral regions. The supra-CQDs were formed by the assembly of surface charge-confined CQDs through electrostatic interactions and hydrogen bonding. They gave rise to a strong visible-NIR absorption (470-1,000 nm) with a PT conversion efficiency of ~ 50%. Similarly, visible-NIR absorption (470-1,000 nm) CQDs embedded in porous carbon nanocapsule shells absorbed and converted NIR light to heat to destroy tumor cells [198] .
With their PT conversion capability and in vivo biocompatibility, CQDs are increasingly being used as potential contrast agents for PA imaging. This is an emerging noninvasive modality based on the detection of ultrasonic waves, which is induced by the thermal expansion of the CQDs upon photon absorption. The mechanism is schematically shown in Fig. 21 . The PA effect provides a higher spatial resolution and deeper tissue penetration compared with most optical imaging techniques [199, 200] .
Early work on CQD-based PA imaging used foodgrade honey to prepare CQDs, which were then coating with PEG. The surface-coated particles were smaller (~ 7 nm) than previously explored particles (Au, SWCNT, Cu) for SLN imaging using the PA effect.
The results indicated rapid signal enhancement (~ 2 min) of the SLN, owing to the strong CQD optical absorption in the NIR region, small size, and rapid lymphatic transport [201] . Red emissive CQDs (500-800 nm, peak at 640 nm) [63] , prepared from conjugated polymer, exhibited a photothermal conversion efficiency of 38.5% under a 671 nm laser. These CQDs acted both as PA and PTT agents for the diagnosis and treatment of cancer in living mice. Recently, glucosederived CQDs were employed as light-absorbing PTT agents with a conversion efficiency of 35.1%; they enabled PT destruction of cancer cells with a PA signal enhancement for in vitro and in vivo PA imaging [200] .
Multiplexed platforms for diagnostics and therapeutics
The emerging field of nanomedicine seeks to revolutionize medical diagnostics and therapy through the development of multifunctional nanoplatforms. Recent advances in engineering CQD probes, and the promising benefits of this technology, have dictated a shift of focus from the synthesis of single-component probes towards the design of complex nanostructures composed of multiple targeting, imaging, and therapeutic modules. For example, CQDs integrated with MRI contrast agents or radionuclides can be used for dual-mode imaging. Alternatively, when combined with drugs or nucleic acid therapeutics, CQDs can serve as traceable delivery vehicles. CQDs are being used as universal scaffolds for the attachment of extra components and targeting ligands due to their large surface area and modular surface chemistry. More importantly, the design of CQD-based multifunctional architectures requires a systematic analysis and formulation so that each functionality may perform independently with no cross-perturbation. Here we selectively present how CQDs are used as a multifunctional platform for imaging, drug delivery, phototherapy, sensing, and monitoring applications.
Although the initial developments of fluorescent nanomaterials were based on optical bioimaging, the current trends are moving towards the integration of multimodal imaging technologies to compensate for the weaknesses of the single imaging modality [202] . CQDs are unique from other fluorophores in terms of their high brightness and photostability, which permit long-term continuous imaging in photon-limited conditions, along with their modular surface chemistry, which enables the conjugation of additional imaging components. As multimodal imaging probes, MRI contrast agents have dominantly been integrated with CQDs [203] [204] [205] [206] [207] [208] . Gd(III)-doped CQDs that combined a high FL with a strong T1-weighted MRI contrast [203] demonstrated their potential as a dual fluorescent-MRI probe. Gd-doped CQDs, grown with a microwaveassisted one-step synthesis, were also applied as bimodal nanoprobes [205] . With a linker, cyclic DTPA dianhydride (cDTPAA), to mediate Gd 3+ and CQD conjugation, the probes showed unperturbed optical properties of the cores with a longitudinal relaxivity of 56.72/(mM·s) and cell-membrane permeability [206] . Multimodal imaging with targeting functionality was incorporated with Gd−CQDs by adding the RGD tripeptide. This provided a high affinity to U87 cancer cells for targeted imaging; therefore, the Gd-CQDs were found in the tissue cells rather than the extracellular matrix. The MR response gave the depth penetration and spatial visualization, whilst the FL revealed the fine distribution of Gd-CQDs in the tissues because of its high resolution and sensitivity. The in vivo MR and FL dual-modality imaging of Gd-CQDs was also confirmed with zebrafish embryo and mouse models. Moreover, Gd-CQDs were observed to have a higher MR response over the clinically used gadopentetic acid dimeglumine (Gd-DTPA) because of their high Gd content and hydrophilicity [204] . In another study, comparing 3.0, 7.4, and 9.6 nm GdCQDs revealed the significant impact of size on the magnetic and optical properties of the nanoparticles, with the smallest showing the highest r1 relaxivity (10/(mM·s) and FL QY (30.2%). These 3.0 nm Gd-CQDs were then conjugated with a tumor-targeting ligand, c(RGDyK), and injected into U87MG xenograft tumor models. Good tumor targeting was observed in the T1-weighted MRI images, whilst the unbound nanoparticles were efficiently excreted through renal clearance, avoiding long-term toxicity to the host [143] . N-doped carbon-iron oxide hybrid quantum dots (C-Fe 3 O 4 QDs) were also reported for triple-modal tumor in vivo bioimaging through FL/MR/computed tomography (CT) [207] .
The CQD-based multiplexing platform for drug delivery represents a beneficial tool for nanomedicine, as functionalities for drug loading, targeting, controlled release, and monitoring of pharmacokinetics and biodistribution can be incorporated within a single unit. The conjugation of the anticancer drug oxaliplatin (Oxa) on amino-capped CQDs via EDC/NHS amidation formed the theranostic nanomedicine Oxa-CQD ( Fig. 22(a) ). This was found to exhibit multiple functions, such as a drug carrier, controlled drug release, and multicolor bioimaging abilities. By monitoring the CQD FL intensity, the distribution of the drug molecules could be followed. The in vivo results suggested that Oxa-CQDs have great potential in cancer diagnostics and therapies [209] . A combination of FL and magnetism, along with ample drug loading and controlled release properties, was endowed on hybrid nanospheres consisting of supermagnetic CoFe 2 O 4 and luminescent mesoporous carbon. Due to the larger anisotropy and saturation magnetization of CoFe 2 O 4 , the hybrid sphere showed a transverse relaxivity as high as 380/(mM·s). The luminescent porous carbon simultaneously exhibited both downconversion and up-conversion FL imaging, high loading, and controlled release of DOX. The dual optical and magnetic properties of the mesoporous spheres showed great promise in multimodal imagingmediated tracking to curative responses [208] . A CQD-based multiplexing gene delivery vehicle was Nano Res. 2018, 11(1): 1-41 designed by the interaction of negatively charged pDNA and CQD-PEI and Au-PEI carriers. Quenching of the FL was triggered by a reduced distance between the CQD-PEI and Au-PEI. FFL imaging revealed that upon internalization of the complex into the cells, FL recovery was proportionally attributed to the gradual dissociation of pDNA from the complex due to transfection. Therefore, simply measuring FL changes at the intracellular level enabled the realtime monitoring of carrier/pDNA association and dissociation, without the labeling of pDNA, and facilitated efficient gene delivery (Fig. 22(b) ) [167] . Integration of a sensing modality with delivery and imaging platforms can help direct the visual monitoring and quantification of intracellular drug release. A FRET-based CQD drug delivery system was developed by the coupling of amino-group terminated PEG onto CQDs followed by the covalent attachment of the folate-targeting agent. Afterwards, DOX was anchored onto the CQD surface via electrostatic interactions and π-π stacking. The simultaneous change in the FRET signal with pH-dependent DOX release was discerned by one-photon imaging. Owing to the large two-photon absorption cross section of the CQDs, this imaging capability of the drug delivery system was further realized at tumor tissues 65-300 mm deep under 810 nm excitation [210] . Raman and FL-based dual-modality imaging was demonstrated during drug delivery based on a CQD thermoresponsive platform [211] .
Phototheranostics, the application of light in the diagnostic imaging and therapy of cancer, has shown great promise for effective multimodal cancer imaging and therapy. CQDs have emerged as ideal platforms, since the intrinsic aromatic and π-conjugated chemical bonds possess an excellent PT conversion ability and can effectively absorb and convert NIR light to heat. By combining fluorescent CQDs with porous carboncoated magnetic Fe 3 O 4 nanoparticles using a one-pot solvothermal method, NIR-responsive multifunctional nanocarriers have been developed [212, 213] . These can realize NIR-controlled drug release and allow combined photothermo/chemotherapy for high therapeutic efficacy. Such CQD-based nanostructured hybrids promise advanced nanoplatforms for simultaneous imaging diagnostics and high efficiency therapeutics. Surface-engineered NIR-absorbing mesoporous carbon nanoparticles (MCNs) were developed as intelligent drug carriers [214] . The MCNs showed a high NIR photothermal conversion by inducing a temperature increase from 20 to 50 °C in 5 min on exposure of 0.1 mg/mL MCN solution to a 2 W/cm 2 NIR laser, with a high drug-loading capacity due to the mesoporous structure. Besides the enzymatic cleavage-controlled drug release from the porous channels of the MCN, 10 min exposure to the NIR laser also enabled photon heating, which dramatically accelerated the drug release from the ungated MCNs. When the NIR laser was turned off, DOX release returned to a slow rate. These results suggest that MCNs can be used as smart drug carriers for dual-triggered synergistic cancer therapies. (Fig. 23(a) ) by synthesizing red emissive CQDs from a conjugated polymer. These displayed a characteristic emission peak at 640 nm with a broad absorption band in the visible to NIR region (400-800 nm). The CQDs showed a high PT conversion efficiency (η = 38.5%) under 671 nm NIR laser irradiation. Meanwhile, CQDs were found to be PA-active agents after intravenous injection into a HeLa tumor-bearing nude mouse model. The simultaneous FL and PA image-guided PTT showed the accumulation of the CQDs in the tumor region owing to enhanced permeability and retention; these caused substantial empyrosis at the tumor site, thereby suppressing tumor growth ( Fig. 23(a) ) [63] . Dual-mode imaging (PL and PA) and phototherapy (PTT and PDT) were combined for a CQD-based phototheranostic platform, where Au nanorods (GNR) were first wrapped by SiO 2 than a CQD coating to form multifunctional GNR@SiO 2 -CQDs ( Fig. 23(b) ). The GNRs served as both PA imaging and PTT agents, and the CQDs as FL imaging and PDT agents (Fig. 23(b) ). The introduction of SiO 2 not only improved the chemical stability of the GNRs and CQDs in the physiological environment but also prevented absolute quenching of CQD FL by the GNRs. These collective properties make GNR@SiO 2 -CQDs a promising phototheranostic agent, in which high sensitivity and good spatial resolution of FL/PA imaging can be achieved to guide PDT/PTT treatments through intravenous administration (Fig. 23(c) ). The combination of PDT and PTT was shown to be more efficient in killing cancer cells compared to PDT or PTT alone under a low laser irradiation dose (≤0.5 W/cm 2 ). The ease of excretion of the GNR@SiO 2 -CQDs from the mice indicated its low toxicity [215] . CQD-based hybrids with silver shells were investigated as bimodal sensitizing agents. The cytotoxicity of the UV radiation or X-rays combined with the nanodots was examined in cancer cells in vitro. Cell viability decreased following exposure to the radiation, whilst the CQDs enhanced the radiation effects by significantly reducing the number of surviving cells compared to cells exposed only to the radiation. Carbon-core silver-shell nanodots have been proposed as a bimodal sensitization platform for biological and medicinal applications employing non-ionizing or ionizing radiation [216] . Figure 24 schematically 
Conclusions and outlook
CQDs have emerged as powerful alternatives to metal-based semiconductor QDs. Factors that favor CQDs include their facile synthetic routes from a range of precursors, and their robust response, biocompatibility, tunability, and stability. As a versatile and tunable stimulus, light provides excellent spatial and temporal manipulation. Thus, the interaction of CQDs with light generates wavelength-dependent optical emissions, charge/electron transfers, and heat generation, which are essential in designing probes for photomediated bioapplications. Engineering of carbogenic cores and surfaces coupled with versatile conjugation strategies enable the tailoring of optical and physicochemical properties for specific applications. The intrinsic photo-induced emissions are primarily influenced by the carbogenic core and the bulk and surface states. The carbogenic core emissions are dependent on the chemical bonding, composition, defect states, and CQD size; emissions from the bulk and surface states are largely influenced by molecular anchoring and surface coatings. The extrinsic photoinduced emissions are mainly influenced by whether a single-or multi-photon stimulus is applied and by variations in solvent, media pH, and CQD concentration. The multi-factor dependencies and heterogeneous FL of CQDs undoubtedly broaden their applications but also pose challenges for the design and deployment of precisely tuned and accurately structured probes. The photomediated charge and heat generation abilities add further value to CQDs for various niche biomedical applications, but the challenging demands of biomedical applications still require further work on suitable precursors, specific tuning of the carbogenic core, and surface functionalization for increases in efficiency. Despite the enormous potential of CQD probes in both diagnostic and therapeutic applications, their clinical use at their current state of development remains challenging. This is primarily because of questions around their potential toxicity and biocompatibility, as well as possible unfavorable pharmacokinetics, biodistribution, and clearance. The main reason is the lack of studies specifically designed for CQD toxicological assessments (e.g., dosage, duration, frequency of exposure, mechanism of action). Many of the studies from which CQD toxicity data have been derived and cited were performed by nanotechnology specialists rather than toxicologists or health scientists. Another reason is that most toxicity studies have been demonstrated via in vitro methods, where experimental conditions are strictly controlled by the investigator, but in vivo physiological environments present complex and often unpredictable responses to foreign materials. In vivo applications often impose additional challenges on probe design, including biocompatible coatings with integrated non-fouling functionality for reduced nonspecific interactions in highly heterogeneous biological environments. The stringent requirements of regulatory authorities for in vivo testing using rodent animal models could be overcome by the use of the more accessible zebrafish model, as indicated by recent trends [217] . A combination of multiple factors, including type of precursor, synthesis route, size, shape, composition, surface chemistry, charge effects, functionalization, and concentration, affect the biocompatibility of CQDs significantly. For detailed information on some of these factors and other secondary aspects, we suggest recent review articles [84, 218, 219] that summarize the biosafety assessment under variable environmental conditions, e.g., specific cell lines, biodistribution, and the pharmacokinetics and pharmacodynamics of CQDs. Since not all CQDs are alike and are dependent on multiple factors, engineered CQDs do not constitute uniform groups of nanomaterials. Hence, each CQD type needs to be characterized individually for its potential toxicity. For CQDs to be clinically relevant, one needs to implement the established protocol for the toxicity screening of nanomaterials set up by the National Academy of Sciences (NAS, USA). The protocol notes that modern biocompatibility and toxicological testing has evolved from predominantly descriptive science-based procedures applied to animal models, to an ultimately predictive scientific discipline, premised on targetspecific and mechanism-based biological screening processes [220] . Compared to metal-based QDs, CQDs show no apparent cytotoxicity and a much-improved biosafety property [221] . The acceptable results of exposure, biodistribution, and clearance of CQDs in vivo [222] may establish its full potential for clinical transformation as stable materials with rapid renal clearance and effective tumor targeting. The novel hierarchical strategies noted in this article provide the guidelines to produce biocompatible probes with hierarchical strategies of grafting and wrapping with biomolecules (Section 3.3) for optimum biosafety. Engineering strategies involving the carbogenic cores, surface chemistry, and bioconjugation can facilitate interactions of CQDs with biological systems and enable direct intervention in biological processes. However, an accurate hierarchical engineering approach is yet to be realized; for example, carbogenic core, surface engineering, or bioconjugation have been developed separately. Thus, matching of the stages involved and overall physicochemical and biological evaluations for integrated theranostics are in their infancy. Clearly, CQDs are ideal platforms for targeted diagnostics such as photomediated sensing and imaging because of their biocompatibility, responses within a wide window, and multi-photon assisted deep-tissue penetration. As theranostic agents, however, further developments are required for improving the sensitivity, reliability, and reproducibility of CQD-based probes by keeping individual functions unperturbed. Image-mediated extracellular investigation within in vivo settings is in its early stages. The development of new types of CQDs with emissions in the red/NIR spectral regions can dramatically expedite progress in the area. Interestingly, CQDs are inherently therapeutic, as they have been shown to be photosensitizers and photothermal agents for the generation of reactive oxygen species and hyperthermia, respectively, which could induce apoptosis in cancer cells. CQDs have also been successful as fluorescent drug carriers for simultaneous trajectory tracking and targeted drug delivery. An emerging trend is towards CQD-based multi-functional nanodevices that can combine the benefits of multiple imaging modalities with inbuilt sensing, imaging, targeting, drug loading, and phototherapeutic capacities within a single platform. However, the varied and sometimes incompatible requirements of the applications create challenges in establishing a framework for reliable CQD-based multifunctional nanoprobes. Most applications have concentrated on treating cancer, while CQD theranostics may significantly assist with neuroscience and infectious diseases. Nevertheless, the exciting field of CQD-based theranostics is set to flourish with cross-disciplinary collaborations between chemists, Nano Res. 2018, 11(1): 1-41 biologists, material scientists, engineers, and clinicians for the benefit of patient management in varied clinical settings.
